Form 8-K - Current report:
SEC Accession No. 0001193125-22-080683
Filing Date
2022-03-21
Accepted
2022-03-21 17:12:02
Documents
28
Period of Report
2022-03-21
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d337066d8k.htm   iXBRL 8-K 24011
2 EX-99.1 d337066dex991.htm EX-99.1 20998
6 GRAPHIC g337066ex99_1s10g1.jpg GRAPHIC 287193
7 GRAPHIC g337066ex99_1s11g1.jpg GRAPHIC 312197
8 GRAPHIC g337066ex99_1s12g1.jpg GRAPHIC 473413
9 GRAPHIC g337066ex99_1s13g1.jpg GRAPHIC 267214
10 GRAPHIC g337066ex99_1s14g1.jpg GRAPHIC 229302
11 GRAPHIC g337066ex99_1s15g1.jpg GRAPHIC 396241
12 GRAPHIC g337066ex99_1s1g1.jpg GRAPHIC 463011
13 GRAPHIC g337066ex99_1s2g1.jpg GRAPHIC 721583
14 GRAPHIC g337066ex99_1s3g1.jpg GRAPHIC 174095
15 GRAPHIC g337066ex99_1s4g1.jpg GRAPHIC 365109
16 GRAPHIC g337066ex99_1s5g1.jpg GRAPHIC 331241
17 GRAPHIC g337066ex99_1s6g1.jpg GRAPHIC 344746
18 GRAPHIC g337066ex99_1s7g1.jpg GRAPHIC 303256
19 GRAPHIC g337066ex99_1s8g1.jpg GRAPHIC 482840
20 GRAPHIC g337066ex99_1s9g1.jpg GRAPHIC 366655
  Complete submission text file 0001193125-22-080683.txt   7780983

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA oric-20220321.xsd EX-101.SCH 2866
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE oric-20220321_lab.xml EX-101.LAB 18738
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE oric-20220321_pre.xml EX-101.PRE 11714
22 EXTRACTED XBRL INSTANCE DOCUMENT d337066d8k_htm.xml XML 3480
Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Filer) CIK: 0001796280 (see all company filings)

EIN.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39269 | Film No.: 22756355
SIC: 2834 Pharmaceutical Preparations